A vaccine against Chikungunya fever, developed by Vienna-based biotech company Themis Bioscience, is now undergoing clinical testing for the first time.
The vaccine, which is based on a standard anti-measles vaccine, offers an opp
British drugmaker GlaxoSmithKline will seek marketing approval for the world's first malaria vaccine next year after trial data showed the shot significantly cut cases of the disease in African children.
An experimental malaria vaccine proved highly effective in a small, early-stage clinical trial in people, raising hope in the global effort to combat the deadly disease, US researchers reported on Thursday in the journal Science.
An early stage study suggests an experimental vaccine may be able to tame bits of the immune system that go haywire in people with type 1 diabetes, offering hope for a new way to delay or prevent the autoimmune disease, researchers said on Wedne
Chinese scientists have developed the first vaccine to protect children against a virus called enterovirus 71, or EV71, that causes the common and sometimes deadly hand, foot and mouth disease (HFMD).
The new inactivated EV71 vacc
After nearly 100 years, researchers could be on the verge of finding a vaccine that would eradicate tuberculosis infections, a scourge that kills 1.4 million people a year.
Global health experts are eagerly awaiting clinical trial
US health regulators have approved a new four-strain seasonal influenza vaccine made by GlaxoSmithKline, the company said.
The US Food and Drug Administration has approved Fluarix Quadrivalent to immunise children age 3 and older
A GlaxoSmithKline experimental malaria vaccine touted as a new weapon in the fight to eradicate the disease proved only 30 percent effective when given to babies as part Africa's largest ever clinical trial.